# Phlox Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/phlox-therapeutics

- Industry: Biotechnology
- Headquarters: North Holland, Netherlands
- Website: www.phloxtherapeutics.com/
- Total disclosed funding: $2.1M
- Latest round: Seed (Nov 6, 2024)
- Investors on record: 4

## About

Founded in 2022 and based in North Holland, Netherlands, Phlox Therapeutics BV specializes in gene therapy aimed at treating genetic heart diseases. Yigal Pinto (CMO) and Eva van Rooij (CSO) are the co-founders of the company. In November 2024, Phlox Therapeutics raised EUR 1.9 million in seed funding from ROM Utrecht Region, including Utrecht Holdings, BioGeneration Ventures, and AMC Ventures Holding.

Phlox Therapeutics specializes in gene therapy to address various genetic heart diseases, focusing primarily on the development of innovative RNA-based therapies for cardiomyopathies. The firm’s core product offerings revolve around precision genetic medicines designed to target the underlying causes of cardiac dysfunction, aiming to alleviate symptoms and halt disease progression. These therapies are intended for patients suffering from rare genetic conditions, particularly genetic laminopathies and other forms of cardiomyopathy. Phlox's solutions are designed for a global market, with a particular emphasis on regions where access to advanced therapeutic options for heart diseases is limited, thereby targeting patients and healthcare providers in North America and Europe.

Phlox Therapeutics engages in transactions primarily through strategic partnerships and collaborations aimed at advancing the research and development of its RNA therapies. Revenue generation may arise from partnerships with research institutions and healthcare organizations that provide access to clinical trial participants and resources for testing these novel therapies.

The organization plans to use the November 2024 funding to accelerate growth and development.

## Funding rounds

- Seed, Nov 6, 2024, $2.1M — BioGeneration Ventures, ROM Utrecht Region, Utrecht Holdings
- Seed, May 9, 2023 — BioGeneration Ventures, Innovatiefonds Noord-Holland, Utrecht Holdings
- Seed, May 16, 2022 — BioGeneration Ventures

## Investors

- BioGeneration Ventures (https://capitalatlas.ai/funds/biogeneration-ventures) — Seed
- Innovatiefonds Noord-Holland (https://capitalatlas.ai/funds/innovatiefonds-noord-holland) — Seed
- Utrecht Holdings (https://capitalatlas.ai/funds/utrecht-holdings) — Seed
- ROM Utrecht Region (https://capitalatlas.ai/funds/rom-utrecht-region) — Seed